Journal article · 2023 · Open access

Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias

Charlotte Elisabeth Teunissen, Leighann Eileithyia Kimble, Sherif Bayoumy, Katharina Bolsewig, Felicia Burtscher, Salomé Coppens, Shreyasee Das, Dea Gogishvili, Bárbara Fernandes Gomes, Nerea Gómez de San José, Ekaterina Mavrina, Francisco J. Meda and 19 more

Molecular & Cellular Proteomics, 22(10), 100629 · Published 7 August 2023 · DOI 10.1016/j.mcpro.2023.100629

Open PDFView at the publisherCite this paper

In brief

“Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias” is a 2023 journal article by Charlotte Elisabeth Teunissen and 30 co-authors, published in Molecular & Cellular Proteomics. OpenAlex counts 62 citations as of 19 November 2026, which puts it in the top 6% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at Molecular & Cellular Proteomics.

Citations
62
Most cited in
2026 (25)
Field-weighted impact
8.99
References
167
Authors
31

Abstract

Neurodegenerative dementias are progressive diseases that cause neuronal network breakdown in different brain regions often because of accumulation of misfolded proteins in the brain extracellular matrix, such as amyloids or inside neurons or other cell types of the brain. Several diagnostic protein biomarkers in body fluids are being used and implemented, such as for Alzheimer's disease. However, there is still a lack of biomarkers for co-pathologies and other causes of dementia. Such biofluid-based biomarkers enable precision medicine approaches for diagnosis and treatment, allow to learn more about underlying disease processes, and facilitate the development of patient inclusion and evaluation tools in clinical trials. When designing studies to discover novel biofluid-based biomarkers, choice of technology is an important starting point. But there are so many technologies to choose among. To address this, we here review the technologies that are currently available in research settings and, in some cases, in clinical laboratory practice. This presents a form of lexicon on each technology addressing its use in research and clinics, its strengths and limitations, and a future perspective.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Teunissen, C. E., Kimble, L. E., Bayoumy, S., Bolsewig, K., Burtscher, F., Coppens, S., Das, S., Gogishvili, D., Gomes, B. F., José, N. G. D. S., Mavrina, E., Meda, F. J., Mohaupt, P., Mravinacová, S., Waury, K., Wojdała, A. L., Abeln, S., Chiasserini, D., Hirtz, C., . . . Zetterberg, H. (2023). Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias. Molecular & Cellular Proteomics, 22(10), 100629. https://doi.org/10.1016/j.mcpro.2023.100629

MLA 9

Teunissen, Charlotte Elisabeth, et al. “Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias.” Molecular & Cellular Proteomics, vol. 22, no. 10, 2023, p. 100629. https://doi.org/10.1016/j.mcpro.2023.100629.

Chicago

Teunissen, Charlotte Elisabeth, Leighann Eileithyia Kimble, Sherif Bayoumy, Katharina Bolsewig, Felicia Burtscher, Salomé Coppens, Shreyasee Das, et al. 2023. “Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias.” Molecular & Cellular Proteomics 22 (10): 100629. https://doi.org/10.1016/j.mcpro.2023.100629.

Harvard

Teunissen, C. E. et al. (2023) ‘Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias’, Molecular & Cellular Proteomics, 22(10), p. 100629. doi:10.1016/j.mcpro.2023.100629.

IEEE

C. E. Teunissen et al., “Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias,” Molecular & Cellular Proteomics, vol. 22, no. 10, p. 100629, 2023, doi: 10.1016/j.mcpro.2023.100629.

BibTeX

@article{teunissen2023methods,
  title     = {{Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias}},
  author    = {Teunissen, Charlotte Elisabeth and Kimble, Leighann Eileithyia and Bayoumy, Sherif and Bolsewig, Katharina and Burtscher, Felicia and Coppens, Salomé and Das, Shreyasee and Gogishvili, Dea and Gomes, Bárbara Fernandes and José, Nerea Gómez de San and Mavrina, Ekaterina and Meda, Francisco J. and Mohaupt, Pablo and Mravinacová, Sára and Waury, Katharina and Wojdała, Anna Lidia and Abeln, Sanne and Chiasserini, Davide and Hirtz, Christophe and Gaetani, Lorenzo and Vermunt, Lisa and Bellomo, Giovanni and Halbgebauer, Steffen and Lehmann, Sylvain and Månberg, Anna and Nilsson, Peter and Otto, Markus and Vanmechelen, Eugeen and Verberk, Inge M.W. and Willemse, Eline A.J. and others},
  journal   = {Molecular \& Cellular Proteomics},
  year      = {2023},
  volume    = {22},
  number    = {10},
  pages     = {100629},
  doi       = {10.1016/j.mcpro.2023.100629},
  url       = {https://doi.org/10.1016/j.mcpro.2023.100629}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202333
20241717
20251717
20262525

Its field-weighted citation impact is 8.99: it has been cited 8.99 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research

  • neurodegenerative dementia
  • Alzheimer's disease
  • biomarker discovery
  • biomarker validation
  • co-pathology
  • misfolded proteins
  • amyloid
  • precision medicine

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Teunissen, C. E., Kimble, L. E., Bayoumy, S., Bolsewig, K., Burtscher, F., Coppens, S., Das, S., Gogishvili, D., Gomes, B. F., José, N. G. D. S., Mavrina, E., Meda, F. J., Mohaupt, P., Mravinacová, S., Waury, K., Wojdała, A. L., Abeln, S., Chiasserini, D., Hirtz, C., . . . Zetterberg, H. (2023). Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias. Molecular & Cellular Proteomics, 22(10), 100629. https://doi.org/10.1016/j.mcpro.2023.100629

How many times has this paper been cited?

62 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Molecular & Cellular Proteomics: sign in and open the PDF from this page.

Who wrote this paper?

Charlotte Elisabeth Teunissen, Leighann Eileithyia Kimble, Sherif Bayoumy, Katharina Bolsewig, Felicia Burtscher, Salomé Coppens, Shreyasee Das, Dea Gogishvili, Bárbara Fernandes Gomes, Nerea Gómez de San José, Ekaterina Mavrina, Francisco J. Meda and 19 more.

What is the DOI of this paper?

10.1016/j.mcpro.2023.100629, permanently at https://doi.org/10.1016/j.mcpro.2023.100629. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.